Clinical Trials Logo

Clinical Trial Summary

The aim of this study is to measure plasma levels of essential vitamins, trace elements and amino acids in critically ill patients with severe AKI. In patients who are treated with continuous renal replacement therapy, we plan to evaluate whether there are any additional losses of nutrients into the filtrate.


Clinical Trial Description

Background: Critically ill patients with acute kidney injury (AKI) have a high risk of dying, especially if renal replacement therapy (RRT) is needed. It remains uncertain whether essential trace elements, vitamins and amino acids are lost during RRT in sufficient amounts to result in clinically significant deficiencies. At present, nutrition guidelines for patients with AKI on RRT do not account for any potential losses of micronutrients across the filter.

Hypothesis:

Critically ill patients with AKI have inadequate plasma nutrient levels. If continuous renal replacement therapy (CRRT) is required, there are additional losses of essential nutrients.

Aims:

To serially measure plasma levels of essential vitamins, trace elements and amino acids in critically ill patients with severe AKI and to evaluate whether there are any additional losses into the filtrate during CRRT

Objectives:

To perform serial measurements of plasma levels of selenium, zinc, copper, iron, vitamins B1, B6, B12, C and D, folic acid and essential amino acids in all patients with severe AKI and to measure any losses of the same nutrients in the filtrate in a cohort of patients on CRRT for >24 hours.

Patient population:

level 3 critically ill adult patients with severe AKI

Study size:

40 patients of whom 20 patients are treated with CRRT for >24 hours.

Study design:

observational non-interventional study in at least 2 large tertiary care centres in the United Kingdom

Outcomes:

Primary outcome: difference in plasma concentrations of essential trace elements and vitamins between patients with and without CRRT.

Secondary outcomes: a) concentrations of trace elements, vitamins and amino acids in filtrate in patients on CRRT; b) differences in filtrate losses between patients on CRRT ≤30ml/kg/hr versus >30ml/kg/hr.

Laboratory measurements:

Measurement of baseline plasma Selenium, Zinc, Copper, iron, Vitamins B1, B6, B12, C and D, folic acid and essential amino acids levels and repeat serial measurement of the same panel of nutrients in all patients for up to 6 days with additional concomitant measurement of nutrient levels in filtrate in cohort of patients on CRRT. In addition, daily measurement of serum electrolytes, liver profile, serum albumin and c-reactive protein.

Data collection:

Recording of the following potential confounders: type of nutrition, dose of CRRT, type of membrane.

Statistics:

Determination of the change in plasma nutrient levels over 6 days, and between baseline and 24 - 144 hours after initiation of CRRT. The estimates will be used to inform the design of an intervention study exploring the value of nutrient supplementation. ;


Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT02470520
Study type Observational
Source Guy's and St Thomas' NHS Foundation Trust
Contact
Status Completed
Phase N/A
Start date August 2013
Completion date November 2015

See also
  Status Clinical Trial Phase
Recruiting NCT00760591 - Change of Neutrophil Gelatinase-Associated Lipocalin(NGAL) Following Sodium Phosphate Bowel Preparation(Pilot Study) N/A
Completed NCT00890214 - Prostacyclin's Effect on Platelet Responsiveness Phase 4
Active, not recruiting NCT03675906 - The Relationship Between Hypoalbuminemia and Development of Acute Kidney Failure (AKI) According to KDIGO Criteria
Recruiting NCT04334707 - Kidney Precision Medicine Project
Active, not recruiting NCT04079829 - Postoperative Respiratory Abnormalities
Recruiting NCT00424320 - Clinical Trial of Sodium Bicarbonate to Prevent Contrast-Induced Nephropathy Phase 3
Completed NCT00472563 - Prevention of Contrast Induced Nephropathy With Sodium Bicarbonate Phase 2/Phase 3
Withdrawn NCT03846258 - High Versus Low Bicarbonate Bath in Critically-ill Patients Receiving Continuous Renal Replacement Therapy Phase 4
Completed NCT06358365 - Enhancing Fluid Transfer Through the Skin, by Increased Sweat Rate, on Hemodialysis Patients N/A
Completed NCT00252200 - BNP (Nesiritide) vs. Placebo to Protect Kidney Function in Patients Undergoing Heart Bypass Surgery. Phase 1/Phase 2
Completed NCT04190979 - Clinical Application of the Medyria TrackCath System in Endovascular Repair of Abdominal Aortic Aneurysms (AAA) N/A
Completed NCT04917497 - Levosimendan Infusion in Critically Ill Patients With Cardiogenic Shock
Recruiting NCT05309291 - Theranova Randomized, Controlled, Trial (RCT) in China N/A
Completed NCT02486614 - Effect of Citrate on the Coagulation System in Patients Receiving CRRT
Active, not recruiting NCT02470507 - Immune Function in Acute Kidney Injury
Active, not recruiting NCT05384899 - Kidney Precision Medicine Project (KPMP) - COVID-19 Protocol
Completed NCT06190522 - Diagnosis of Acute Obstructive Renal Failure by Clinical Ultrasound Performed by the Emergency Physician.
Recruiting NCT04221932 - Implementation of CRRT KPI Reports to Standardize and Improve the Quality of CRRT Delivery in Alberta "QUALITY CRRT"
Active, not recruiting NCT01122225 - Neutrophile Gelatinase Associated Lipocalin Evaluation in Septic Acute Kidney Injury N/A
Completed NCT00529139 - Hannover Dialysis Outcome Study Phase 4